Effects of vaccination against infectious diseases on the pediatric population in Panama

Authors

  • Nurilys Ponce Fundación Social, Educativa y Cultural del Claustro Gómez. Chiriquí, Panamá.
  • Joel Magallón Fundación Social, Educativa y Cultural del Claustro Gómez. Chiriquí, Panamá.
  • Felipe Cedeño Fundación Social, Educativa y Cultural del Claustro Gómez. Chiriquí, Panamá.
  • Samuel Espinoza Fundación Social, Educativa y Cultural del Claustro Gómez. Chiriquí, Panamá.
  • Lorena Cedeño Fundación Social, Educativa y Cultural del Claustro Gómez. Chiriquí, Panamá.
  • Kenia Góndola Fundación Social, Educativa y Cultural del Claustro Gómez. Chiriquí, Panamá.
  • Dorada Icaza Fundación Social, Educativa y Cultural del Claustro Gómez. Chiriquí, Panamá.
  • Yuanlin Loré Fundación Social, Educativa y Cultural del Claustro Gómez. Chiriquí, Panamá.
  • Bertilia Jiménez Fundación Social, Educativa y Cultural del Claustro Gómez. Chiriquí, Panamá.
  • Mónica Cantillo Cantillo Fundación Social, Educativa y Cultural del Claustro Gómez. Chiriquí, Panamá.
  • Milagro Rodríguez Fundación Social, Educativa y Cultural del Claustro Gómez. Chiriquí, Panamá.

Keywords:

Strengthening public health partnerships, Equity in vaccination, Vaccine-preventable diseases, Infant mortality, Expanded Immunization Program in the Americas

Abstract

The Expanded Immunization Program in the Americas is considered one of the most successful experiences in public health due to its valuable contribution to reducing infant mortality caused by vaccine-preventable diseases in the region. Indeed, since its launch, our countries have successfully halted the transmission of wild poliovirus since 1991, as well as the indigenous circulation of measles virus since November 2002, and are making progress in eliminating rubella and congenital rubella syndrome. Additionally, national immunization programs make significant efforts to identify vulnerable populations and reduce vaccination inequities. To sustain the achievements and address new challenges, such as the introduction of new vaccines, it is necessary to strengthen partnerships among governments, donor organizations, the private sector, scientific associations, and society as a whole. In this context, PAHO (Pan American Health Organization) promotes the highest technical quality through the presentation of practical guidelines prepared by the Immunization Unit of the Family and Community Health Area

References

Cullar-Rodríguez, J. M., & Mota-Valtierra, C. D. (2018). Inmunizaciones en candidatos y receptores de trasplante de riñón e hígado.

González, A. M., López, J. R., & Martínez, S. F. (2021). Efectos de la vacunación hexavalente en la población infantil. Revista de Salud Pública, 45(3), 215-230.

González, A. M. et al. (2021). Safety of Hexavalent Vaccination in Panamanian Children. Public Health Journal, 55(3), 215-228.

López, J. R. et al. (2019). Severe Adverse Reactions to Hexavalent Vaccination: A Rare Occurrence. Vaccine Safety Review, 30(2), 87-96.

Martínez, S. A. et al. (2020). The Importance of Active Surveillance of Adverse Events in Hexavalent Vaccination. Journal of Public Health, 45(4), 321-334.

Pérez, M. A. (2019). Impacto de la vacunación hexavalente en Panamá: Un análisis epidemiológico. Journal of Vaccination, 12(2), 87-96.

Pérez, L. M. et al. (2021). Transparent Communication on Vaccine Safety: Building Public Trust. Vaccine Information, 22(1), 45-56.

Revista Médica MD, 9.10 (4), 345–351. https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=82634

Lüthy, I. A., & Kantor, I. N. (2020). Sarampión. Medicina, 80(2), 162–168. http://www.scielo.org.ar/scielo.php?pid=S0025-76802020000300011&script=sci_arttext

(S/f). Recuperado el 1 de noviembre de 2023, de http://file:///C:/Users/usuario/Downloads/2023-octubre-phe-alerta-epidemiologica-sarampion-final.pdf

Vista de Difteria en la Región “Una amenaza constante y potencialmente letal”. Estrategia de inmunización durante el curso de vida. (s/f). Org.pe. Recuperado el 2 de noviembre de 2023, de https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/1636/652

(S/f). Recuperado el 1 de noviembre de 2023, de http://file:///C:/Users/gondo/Downloads/Dialnet-VacunacionDeLaTosferinaEnLaEmbarazadaYProteccionDe-6282775.pdf, https://www.cdc.gov/vaccines/parents/diseases/polio-sp.html, https://cevaxin.com/blog/blog-1/post/la-lucha-contra-la-poliomielitis-y-cevaxin-como-agente-de-cambio-2

Organización Mundial de la Salud. Plan de vacunación, contraindicaciones y reacciones adversas, Vacunas contra la influenza. Boletín Epidemiológico Semanal. 2005; 80:279-28 World Health Organization (Organización Mundial de la Salud): Centers for Disease Control and Prevention (CDC): El CDC de los Estados Unidos (www.cdc.gov). María Ester López (junio 2016) Influenza: un enfoque epidemiológico. Comunidad y Salud vol.14 no.2 Maracay dic. 2016 http://ve.scielo.org/scielo.php?script=sci Rebecca C Brady. 2010 Aug;21(2):236-50, Viii Influenza. https://pubmed.ncbi.nlm.nih.gov/21047027

Published

2024-02-10

How to Cite

Ponce, N. ., Magallón, J. ., Cedeño, F. ., Espinoza, S. ., Cedeño, L. ., Góndola, K. ., Icaza, D. ., Loré, Y. ., Jiménez, B. ., Cantillo, M. C., & Rodríguez, M. . (2024). Effects of vaccination against infectious diseases on the pediatric population in Panama . Multidisciplinary &Amp; Health Education Journal, 6(1), 957–978. Retrieved from http://journalmhe.org/ojs3/index.php/jmhe/article/view/127